Skip to main content

Table 2 Lymphocyte subsets (%) on blood of patients with NMO and MS

From: Expression of chemokine receptors on peripheral blood lymphocytes in multiple sclerosis and neuromyelitis optica

PB measurements (%)

Lymphocyte subsets

NMO (n = 12)

MS (n = 24)

NC (n = 25)

P value

  
     

NMO vs NC

MS vs NC

NMO vs MS

Lymphocyte

 

18.8 ± 1.8

25.7 ± 2.0

35.4 ± 1.8

<0.001*

0.001*

0.009*

CD3+

T cell

73.5 ± 2.6

70.2 ± 1.7

66.1 ± 1.7

0.039

0.071

0.486

CD3+CD4+

Th/Ti

40.8 ± 2.9

41.6 ± 2.2

38.8 ± 1.3

0.212

0.045

0.837

CD3+CD8+

Ts/Tc

31.5 ± 2.7

28.4 ± 1.7

26.4 ± 1.4

0.205

0.321

0.767

CD3+CD19+

B cell

15.4 ± 2.0

17.0 ± 1.2

17.3 ± 0.9

0.527

0.810

0.600

CD4+CD25+

 

16.8 ± 2.3

17.0 ± 1.4

11.4 ± 0.9

0.051

<0.001*

0.674

CD4+CD45RO+

Memory T

28.0 ± 2.4

27.1 ± 1.6

23.0 ± 0.9

0.039

0.007*

0.810

CD4+CD45RA+

Naïve T

22.9 ± 2.7

26.9 ± 2.0

25.8 ± 1.5

0.427

0.656

0.289

CD4+CXCR3+

Th1

23.9 ± 3.5

24.9 ± 2.4

19.6 ± 1.9

0.188

0.039

0.722

CD4+CCR5+

Th1

0.7 ± 0.2

1.0 ± 0.3

1.4 ± 0.3

0.112

0.062

0.730

CD4+CCR4+

Th2

25.2 ± 2.1

26.9 ± 1.9

26.4 ± 1.4

0.602

0.785

0.470

CD4+CCR3+

Th2

1.1 ± 0.2

0.9 ± 0.2

1.8 ± 0.2

0.022

0.001*

0.272

CD8+CXCR3+

Tc1

21.1 ± 4.1

18.3 ± 1.0

15.4 ± 1.9

0.183

0.020

0.844

CD8+CCR4+

Tc2

9.5 ± 2.4

6.9 ± 0.7

9.6 ± 0.9

0.355

0.017

0.952

CD4+CXCR3+/CD4+CCR4+

Th1/2

1.0 ± 0.1

1.0 ± 0.1

0.8 ± 0.1

0.122

0.023

0.908

CD4+CXCR3+/CD4+CCR3+

Th1/2

31.4 ± 9.4

23.1 ± 2.4

13.7 ± 1.9

0.035

0.007*

0.966

CD4+CCR5+/CD4+CCR4+

Th1/2

0.03 ± 0.01

0.03 ± 0.01

0.06 ± 0.01

0.093

0.041

0.646

CD4+CCR5+/CD4+CCR3+

Th1/2

0.7 ± 0.2

1.2 ± 0.3

0.8 ± 0.1

0.520

0.754

0.453

CD8+CXCR3+/CD8+CCR4+

Tc1/2

3.4 ± 0.6

3.4 ± 0.5

2.0 ± 0.3

0.056

<0.001*

0.738

  1. Values indicate mean ± standard error, PB: peripheral blood, NMO: neuromyelitis optica, MS: multiple sclerosis, HC: healthy control, Th: helper Tcell, Ti: inducer T, Ts: suppressor T, Tc: cytotoxic T, CCR: CC chemokine receptor, CXCR: CXC chemokine receptor. *Statistically significantly even after multiple comparison adjustment.